What is the recommended dose of intramuscular (IM) ampicillin-sulbactam for a 5-month-old patient weighing 7 kilograms (kg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IM Ampicillin-Sulbactam Dosing for 5-Month-Old, 7kg Patient

For a 5-month-old infant weighing 7kg, administer ampicillin-sulbactam 50 mg/kg IM (350 mg total dose) within 30 minutes before a procedure if used for endocarditis prophylaxis, or 200-300 mg/kg/day divided every 6 hours (350-525 mg per dose) for treatment of active infections.

Dosing Based on Clinical Indication

For Endocarditis Prophylaxis (Single Dose)

  • The American Heart Association recommends 50 mg/kg IM or IV within 30 minutes before the procedure for pediatric patients unable to take oral medications 1
  • For this 7kg infant: 50 mg/kg × 7kg = 350 mg as a single IM dose 1
  • This dose should not exceed the adult dose of 2.0 g 1

For Active Infection Treatment (Multiple Doses)

  • The American Heart Association recommends 200-300 mg/kg/day IV in 4-6 equally divided doses for pediatric endocarditis 2
  • For complicated intra-abdominal infections, 200 mg/kg/day given every 6 hours is recommended 2
  • For this 7kg infant using 200 mg/kg/day: 200 mg/kg × 7kg = 1400 mg/day ÷ 4 doses = 350 mg every 6 hours 2
  • For this 7kg infant using 300 mg/kg/day: 300 mg/kg × 7kg = 2100 mg/day ÷ 4 doses = 525 mg every 6 hours 2

Pharmacokinetic Considerations in Infants

  • Pharmacokinetic studies demonstrate that ampicillin-sulbactam in pediatric patients aged 1-12 years achieves mean peak concentrations of 177-200 mcg/mL for ampicillin and 82-102 mcg/mL for sulbactam 3
  • The mean half-life is approximately 0.77 hours for ampicillin and 0.81 hours for sulbactam in children 3
  • Age does not significantly affect the pharmacokinetics of ampicillin or sulbactam in pediatric patients, and the combination is well tolerated 3, 4

Route of Administration Considerations

  • IM administration is appropriate when the patient cannot tolerate oral medications 1
  • The 2:1 ratio of ampicillin to sulbactam is maintained in all formulations 3, 5
  • For severe infections requiring higher doses (75 mg/kg q.i.d.), IV administration may be preferred over IM due to injection volume and tissue tolerance 4

Common Pitfalls to Avoid

  • Do not underdose based on age alone - the pharmacokinetics in infants are comparable to older children and adults, so weight-based dosing is appropriate 3, 4
  • Ensure proper dosing interval - the short half-life (approximately 0.8 hours) necessitates every 6-hour dosing for therapeutic infections 3, 5
  • For empiric therapy of serious infections like pneumonia, consider that 45 mg/kg three times daily may be insufficient - 75 mg/kg four times daily provides better coverage against common pathogens with higher MIC values 4
  • Monitor for adequate clinical response - if treating an active infection rather than prophylaxis, the higher end of the dosing range (300 mg/kg/day) may be necessary for severe infections 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Unasyn Dosing Guidelines for Specific Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics of ampicillin and sulbactam in pediatric patients.

Antimicrobial agents and chemotherapy, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.